| TF Name |
Cell-line |
Condition/Source |
Collections |
Species |
Identifiers |
JASPAR ID |
| CREB1 |
K562 (myelogenous leukemia) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000BSO
|
MA0018.4
|
| CREB3L1 |
K562 (myelogenous leukemia) |
|
Permissive
|
Homo sapiens |
ENCSR109YGM
|
MA0839.1
|
| CREM |
K562 (myelogenous leukemia) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR077DKV
|
MA0609.2
|
| CTCF |
K562 (myelogenous leukemia) |
5-aza-2’-deoxycytidine (decitabine; Sigma, A3656) dissolved in DMSO to 10mM. Drug was administered at 1uM daily for 3 days. Control K562 cells were mock treated with DMSO. |
Permissive
Robust
|
Homo sapiens |
GSE50610
...
|
MA0139.1
|
| CTCF |
K562 (myelogenous leukemia) |
none |
Permissive
Robust
|
Homo sapiens |
GSE50611
...
|
MA0139.1
|
| CTCF |
K562 (myelogenous leukemia) |
+DOX 3 days, mutant CTCF |
Permissive
Robust
|
Homo sapiens |
GSE92879
...
|
MA0139.1
|
| CTCF |
K562 (myelogenous leukemia) |
Treatment: None; |
Permissive
Robust
|
Homo sapiens |
GSE29611
...
|
MA0139.1
|
| CTCF |
K562 (myelogenous leukemia) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000AKO
|
MA0139.1
|
| CTCF |
K562 (myelogenous leukemia) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000BPJ
|
MA0139.1
|
| CTCF |
K562 (myelogenous leukemia) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000DMA
|
MA0139.1
|
Showing 10 records in page 3
from 25 pages